- Home
- BHVN vs CPRI Comparison
BHVN vs CPRI Comparison
Compare BHVN & CPRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHVN
- CPRI
- Stock Information
- Founded
- BHVN 2013
- CPRI 1981
- Country
- BHVN United States
- CPRI United Kingdom
- Employees
- BHVN N/A
- CPRI N/A
- Industry
- BHVN Biotechnology: Pharmaceutical Preparations
- CPRI Apparel
- Sector
- BHVN Health Care
- CPRI Consumer Discretionary
- Exchange
- BHVN Nasdaq
- CPRI Nasdaq
- Market Cap
- BHVN 1.9B
- CPRI 2.0B
- IPO Year
- BHVN 2017
- CPRI 2011
- Fundamental
- Price
- BHVN $14.45
- CPRI $16.82
- Analyst Decision
- BHVN Strong Buy
- CPRI Buy
- Analyst Count
- BHVN 14
- CPRI 11
- Target Price
- BHVN $58.85
- CPRI $21.91
- AVG Volume (30 Days)
- BHVN 2.1M
- CPRI 3.2M
- Earning Date
- BHVN 08-07-2025
- CPRI 08-07-2025
- Dividend Yield
- BHVN N/A
- CPRI N/A
- EPS Growth
- BHVN N/A
- CPRI N/A
- EPS
- BHVN N/A
- CPRI N/A
- Revenue
- BHVN N/A
- CPRI $4,442,000,000.00
- Revenue This Year
- BHVN N/A
- CPRI N/A
- Revenue Next Year
- BHVN $59.97
- CPRI $4.55
- P/E Ratio
- BHVN N/A
- CPRI N/A
- Revenue Growth
- BHVN N/A
- CPRI N/A
- 52 Week Low
- BHVN $13.87
- CPRI $11.86
- 52 Week High
- BHVN $55.70
- CPRI $43.34
- Technical
- Relative Strength Index (RSI)
- BHVN 33.35
- CPRI 46.41
- Support Level
- BHVN $14.95
- CPRI $16.75
- Resistance Level
- BHVN $17.73
- CPRI $17.50
- Average True Range (ATR)
- BHVN 0.87
- CPRI 0.67
- MACD
- BHVN 0.04
- CPRI -0.12
- Stochastic Oscillator
- BHVN 15.03
- CPRI 14.44
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
About CPRI Capri Holdings Limited
Michael Kors, Versace, and Jimmy Choo are the brands of Capri Holdings, a marketer, distributor, and retailer of upscale accessories and apparel. Michael Kors, Capri's largest brand, offers handbags, footwear, and apparel through more than 700 company-owned stores, wholesale, and e-commerce. Versace (acquired in 2018) is known for its ready-to-wear luxury fashion, while Jimmy Choo (acquired in 2017) is best known for women's luxury footwear. In April 2025, Capri agreed to sell Versace to Prada. John Idol has served as Capri's CEO since 2003.